Literature DB >> 16636331

Questions about Adderall XR.

Pierre Biron, Barbara Mintzes, Joel Lexchin.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16636331      PMCID： PMC1435951          DOI： 10.1503/cmaj.1060004

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Inconclusive evidence puts Adderall back on the market.

Authors:  Wayne Kondro
Journal:  CMAJ       Date:  2005-10-11       Impact factor: 8.262

2.  A study of compliance with FDA recommendations for pemoline (Cylert).

Authors:  Mary E Willy; Bharati Manda; Deborah Shatin; Carol R Drinkard; David J Graham
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-07       Impact factor: 8.829
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.